您的购物车当前为空
别名 HDAC6 Inhibitor, BML-281
CAY10603 (BML-281) 是一种选择性 HDAC6抑制剂,IC50值为 2 pM。它也可抑制 HDAC1、HDAC2、HDAC3、HDAC8 和 HDAC10,IC50值分别为 271、252、0.42、6851和90.7 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
CAY10603 (BML-281) 是一种选择性 HDAC6抑制剂,IC50值为 2 pM。它也可抑制 HDAC1、HDAC2、HDAC3、HDAC8 和 HDAC10,IC50值分别为 271、252、0.42、6851和90.7 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 362 | In Stock | |
| 2 mg | ¥ 523 | In Stock | |
| 5 mg | ¥ 887 | In Stock | |
| 10 mg | ¥ 1,470 | In Stock | |
| 25 mg | ¥ 2,890 | In Stock | |
| 50 mg | ¥ 4,280 | In Stock | |
| 100 mg | ¥ 5,970 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 889 | In Stock |
CAY10603 相关产品
| 产品描述 | CAY10603 (BML-281) is a potent and selective inhibitor of HDAC6. |
| 靶点活性 | HDAC8:6851 nM, HDAC6:2 pM, HDAC3:0.42 nM, HDAC2:252 nM, HDAC1:271 nM, HDAC10:90.7 nM |
| 体内活性 | CAY10603通过抑制HDAC6,表现出对胰腺癌细胞系有效的抗增殖活性,IC50 <1 μM。 |
| 激酶实验 | HDAC Inhibition Assays: Purified HDACs are incubated with 1 mM carboxyfluorescein (FAM)-labeled acetylated peptide substrate and test compound for 17 h at 25 °C in HDAC assay buffer containing 100 mM HEPES (pH 7.5), 25 mM KCl, 0.1% BSA, and 0.01% Triton X-100. Reactions are terminated by the addition of buffer containing 0.078% SDS for a final SDS concentration of 0.05%. Substrate and product are separated electrophoretically using a Caliper LabChip 3000 system with blue laser excitation and green fluorescence detection (CCD2). The fluorescence intensity in the substrate and product peaks is determined using the Well Analyzer software on the Caliper system. The reactions are performed in duplicate for each sample. IC50 values are automatically calculated using the IDBS XLFit version 4.2.1 plug-in for Microsoft Excel and the XLFit 4-Parameter Logistic Model: ((A+((B_A)/1+((C/x)D)))), in which x is compound concentration, A and B are respectively the estimated minimum and maximum of percent inhibition, C is the inflection point, and D is the Hill slope of the sigmoidal curve. The standard errors of the IC50 values are automatically calculated using the IDBS XLFit version 4.2.1 plug-in for Microsoft Excel and the formula xf4_FitResultStdError. |
| 细胞实验 | The pancreatic cancer cell lines BxPc-3, HupT3, Mia Paca-2, Panc 04.03, and SU 86.86 are grown in medium (DMEM or RPMI) containing 10% fetal calf serum and l-glutamine. Pancreatic cancer cells are plated out in duplicate into 6 wells of a 96-well microtiter plate. Four hours post plating, individual wells are treated with diluent (DMSO) or varying concentrations of SAHA or the indicated HDACIs from a concentration of 1 nM to 50 mM. Cytotoxicity is measured at time "0", and 72 h post treatment using the colorimetric MTT assay according to the manufacturer's suggestions. The IC50 values are calculated using XLfit.(Only for Reference) |
| 别名 | HDAC6 Inhibitor, BML-281 |
| 分子量 | 446.5 |
| 分子式 | C22H30N4O6 |
| CAS No. | 1045792-66-2 |
| Smiles | C(NCCCCCCC(NO)=O)(=O)C=1C=C(ON1)C2=CC=C(NC(OC(C)(C)C)=O)C=C2 |
| 密度 | 1.231 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: 5 mg/mL (11.19 mM), Heating is recommended. DMSO: 82 mg/mL (183.65 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.39 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容